- Investing Ideas
- Swedish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Swedish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
42
Companies which are more than 50% undervalued based on analyst price target.
42 companies
Bonesupport Holding
Market Cap: SEK 14.8b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 225.20
7D
1.2%
1Y
-26.4%
Hansa Biopharma
Market Cap: SEK 4.1b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 40.48
7D
21.2%
1Y
44.6%
Swedencare
Market Cap: SEK 3.4b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 21.55
7D
-1.6%
1Y
-38.9%
Egetis Therapeutics
Market Cap: SEK 3.2b
A pharmaceutical company, engages in the development and commercialization of orphan drugs in Sweden and internationally.
EGTX
SEK 6.94
7D
8.8%
1Y
27.6%
Vicore Pharma Holding
Market Cap: SEK 3.2b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 11.46
7D
3.4%
1Y
-3.9%
BioInvent International
Market Cap: SEK 1.5b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally.
BINV
SEK 22.95
7D
-0.4%
1Y
-38.0%
Cereno Scientific
Market Cap: SEK 1.5b
A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden.
CRNO B
SEK 4.74
7D
-0.8%
1Y
-47.9%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 19.82
7D
3.8%
1Y
-26.9%
Medivir
Market Cap: SEK 1.1b
A pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.
MVIR
SEK 1.82
7D
1.4%
1Y
-7.8%
Devyser Diagnostics
Market Cap: SEK 1.1b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 62.60
7D
-4.3%
1Y
-57.6%
SynAct Pharma
Market Cap: SEK 1.0b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 18.56
7D
-2.8%
1Y
-4.6%
AlzeCure Pharma
Market Cap: SEK 943.2m
Operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 6.84
7D
8.6%
1Y
68.9%
Xspray Pharma
Market Cap: SEK 654.3m
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 13.80
7D
-16.9%
1Y
-73.2%
Oncopeptides
Market Cap: SEK 630.1m
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 1.59
7D
-0.4%
1Y
-64.6%
Cinclus Pharma Holding
Market Cap: SEK 562.2m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 12.08
7D
1.0%
1Y
-28.4%
Orexo
Market Cap: SEK 507.1m
A pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 14.52
7D
-1.2%
1Y
-25.5%
FluoGuide
Market Cap: SEK 505.2m
A clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark.
FLUO
SEK 30.90
7D
-0.3%
1Y
-25.9%
Corline Biomedical
Market Cap: SEK 471.7m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.
CLBIO
SEK 18.05
7D
2.8%
1Y
38.8%
Cantargia
Market Cap: SEK 448.7m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 1.81
7D
0.3%
1Y
-39.4%
Mendus
Market Cap: SEK 413.0m
A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.
IMMU
SEK 6.48
7D
-5.7%
1Y
-17.5%
Intervacc
Market Cap: SEK 411.7m
Develops novel veterinary vaccines for animals in Sweden.
IVACC
SEK 1.21
7D
-4.3%
1Y
12.9%
Isofol Medical
Market Cap: SEK 279.5m
Operates as a clinical stage biotech company.
ISOFOL
SEK 0.87
7D
8.5%
1Y
1.4%
IRLAB Therapeutics
Market Cap: SEK 227.5m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other central nervous system (CNS) disorders in the United States.
IRLAB A
SEK 1.53
7D
15.4%
1Y
-51.0%
Alzinova
Market Cap: SEK 204.3m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 1.01
7D
-3.3%
1Y
-20.1%
Xbrane Biopharma
Market Cap: SEK 197.4m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 9.58
7D
-5.6%
1Y
-73.7%
Elicera Therapeutics
Market Cap: SEK 196.9m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 2.95
7D
25.5%
1Y
-51.9%
Initiator Pharma
Market Cap: SEK 178.0m
A clinical-stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous systems.
INIT
SEK 2.60
7D
10.6%
1Y
-25.5%
KDventures
Market Cap: SEK 161.5m
A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.
KDV B
SEK 0.24
7D
0.4%
1Y
-75.0%
Nanologica
Market Cap: SEK 150.2m
A life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United States, and internationally.
NICA
SEK 0.46
7D
0.4%
1Y
-68.4%
Active Biotech
Market Cap: SEK 138.4m
A biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden.
ACTI
SEK 5.25
7D
-0.6%
1Y
-69.2%
NextCell Pharma
Market Cap: SEK 130.2m
A biopharmaceutical company, engages in the research, development, and manufacture of stromal cell therapies in Sweden.
NXTCL
SEK 1.03
7D
-2.1%
1Y
-14.3%
Vivesto
Market Cap: SEK 97.2m
Develops, develops, markets, and sells drugs in the field of human and veterinary oncology in Sweden.
VIVE
SEK 8.78
7D
-1.6%
1Y
-63.6%
Annexin Pharmaceuticals
Market Cap: SEK 91.8m
A clinical stage biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.
ANNX
SEK 13.00
7D
4.0%
1Y
-53.9%
IDL Diagnostics
Market Cap: SEK 91.2m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.40
7D
2.1%
1Y
-28.8%
OncoZenge
Market Cap: SEK 87.2m
A clinical-stage pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.
ONCOZ
SEK 6.21
7D
-2.1%
1Y
-3.4%
Ascelia Pharma
Market Cap: SEK 77.5m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 0.58
7D
-4.1%
1Y
-87.9%